Skip to main content
Clinical Trials/ACTRN12624000146594
ACTRN12624000146594
Recruiting
未知

Assessment of regional lung ventilation via X-ray velocimetry (XV) imaging following thecommencement of ETI (elexacaftor/tezacaftor/ivacaftor) treatment in children with cystic fibrosis

Women's and Children's Hospital0 sites20 target enrollmentFebruary 15, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
cystic fibrosis
Sponsor
Women's and Children's Hospital
Enrollment
20
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Women's and Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • Children with cystic fibrosis aged 5\-18 years planning to start ETI (elexacaftor/tezacaftor/ivacaftor) treatment in the next 3 months
  • \- must have a clinically indicated CT chest completed prior to screening or scheduled within the next 4 weeks
  • \- must be willing to attempt all lung function testing and complete one of: spirometry, lung volumes, diffusing capacity, multiple breath washout

Exclusion Criteria

  • \- pulmonary exacerbation within 4 weeks of planned screening visit
  • \- currently receiving mechanical ventilation, intensive or other critical care
  • \- contraindication to ionising radiation
  • \- inability to remain still for periods of 30 seconds for each of the 5 XV image acquisitions during an XV scan
  • \- use of ETI (elexacaftor/tezacaftor/ivacaftor) before Screening procedures are complete

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Feasibility of Regional Lung Ventilation using X-Ray Velocimetry (XV) in Adult Patients with Chronic Respiratory Conditions.Chronic Obstructive Pulmonary Disease (COPD)AsthmaCystic Fibrosis (CF)Idiopathic Pulmonary Fibrosis (IPF)Primary ciliary dyskinesia (PCD)Respiratory - Chronic obstructive pulmonary diseaseRespiratory - AsthmaRespiratory - Other respiratory disorders / diseasesHuman Genetics and Inherited Disorders - Cystic fibrosis
ACTRN12623000889651niversity of New South Wales60
Completed
Not Applicable
Visualization of regional lung ventilation using Electrical Impedance Tomography (EIT)Ventilation in healthy lungs10013369
NL-OMON42254Medisch Universitair Ziekenhuis Maastricht16
Active, not recruiting
Not Applicable
ung imaging using hyperpolarized xenon gas MR imaging in patients with lung cancer after radiotherapyon-small cell lung cancer.MedDRA version: 16.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2011-002028-41-GBOxford University Hospitals NHS Trust
Not yet recruiting
Not Applicable
Regional ventilation distribution in patients with severe emphysema determined by electrical impedance tomography before and after endoscopic valve therapy for lung volume reductioJ43J44EmphysemaOther chronic obstructive pulmonary disease
DRKS00009991Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Campus Kiel20
Recruiting
Not Applicable
Investigation of lung ventilation during intensive care treatments measured by electrical impedance tomography in mechanically ventilated patients.Observational study: ventilated patients are monitored by EIT during 24 hours
DRKS00010832Fachkrankenhaus Coswig GmbHAbteilung Anästhesiologie/Intensivtherapie30